| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.781 | 3.691 | 1.893 | 10.872 | 8.830 | 0 | 1.541 | 1.365 | 0 |
| Total Income - EUR | - | 3.781 | 3.691 | 1.893 | 10.872 | 8.830 | 0 | 1.541 | 1.365 | 0 |
| Total Expenses - EUR | - | 1.665 | 541 | 1.036 | 280 | 119 | 74 | 117 | 969 | 1.160 |
| Gross Profit/Loss - EUR | - | 2.116 | 3.150 | 858 | 10.591 | 8.711 | -74 | 1.424 | 396 | -1.160 |
| Net Profit/Loss - EUR | - | 2.003 | 3.039 | 801 | 10.265 | 8.465 | -74 | 1.379 | 334 | -1.160 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tekra Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 583 | 286 | 0 | 0 | 0 | 0 | 0 | 1.652 | 726 |
| Current Assets | - | 1.646 | 2.965 | 3.886 | 10.711 | 13.008 | 6.824 | 2.583 | 555 | 425 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 2.079 | 2.912 | 8.135 | 5.089 | 983 | 1.901 | 64 | 64 |
| Cash | - | 1.646 | 886 | 974 | 2.576 | 7.919 | 5.842 | 682 | 491 | 362 |
| Shareholders Funds | - | 2.047 | 3.092 | 3.836 | 10.347 | 12.930 | 6.824 | 1.428 | 382 | -780 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 181 | 159 | 50 | 364 | 78 | 0 | 1.155 | 1.825 | 1.931 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Tekra Med Srl